You are here

  • Home
  • Archive
  • Volume 10, Issue 4
  • Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy

Article metrics

Article menu
Basic tumor immunology
Original research
Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy

 

Online download statistics by month:

Online download statistics by month: April 2022 to September 2025

AbstractFullPdf
Apr 2022189190110
May 2022333342150
Jun 202218218670
Jul 202214717674
Aug 202215716039
Sep 202211711953
Oct 202213614236
Nov 202211511744
Dec 2022818128
Jan 2023686929
Feb 2023929443
Mar 2023646548
Apr 2023798265
May 2023555541
Jun 2023414118
Jul 2023565619
Aug 2023787938
Sep 2023484823
Oct 2023565737
Nov 2023404035
Dec 2023515138
Jan 2024495034
Feb 2024555639
Mar 2024596351
Apr 2024565733
May 2024667032
Jun 2024747829
Jul 20248691129
Aug 20247580129
Sep 2024727544
Oct 2024757732
Nov 202411111247
Dec 2024616523
Jan 2025616227
Feb 2025687125
Mar 2025747534
Apr 2025788039
May 2025848437
Jun 2025525520
Jul 2025110
Sep 2025110
Total344335531842